MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that Gregory D. Perry and Zohar Loshitzer have been appointed to the company’s Board of Directors, effective today.
